A detailed history of Alaska Permanent Fund Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 54,135 shares of EXEL stock, worth $1.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
54,135
Previous 54,135 -0.0%
Holding current value
$1.8 Million
Previous $1.22 Million 15.46%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$20.34 - $23.73 $18,224 - $21,262
896 Added 1.68%
54,135 $1.22 Million
Q1 2024

Apr 09, 2024

BUY
$20.17 - $23.93 $12,444 - $14,764
617 Added 1.17%
53,239 $1.26 Million
Q4 2023

Feb 01, 2024

BUY
$19.25 - $24.13 $226,514 - $283,937
11,767 Added 28.8%
52,622 $1.26 Million
Q3 2023

Oct 31, 2023

BUY
$19.04 - $22.74 $11,347 - $13,553
596 Added 1.48%
40,855 $892,000
Q2 2023

Jul 31, 2023

SELL
$18.17 - $20.48 $200,215 - $225,669
-11,019 Reduced 21.49%
40,259 $769,000
Q4 2022

Feb 08, 2023

BUY
$14.96 - $17.39 $7,345 - $8,538
491 Added 0.97%
51,278 $822,000
Q3 2022

Oct 31, 2022

BUY
$15.68 - $22.27 $14,551 - $20,666
928 Added 1.86%
50,787 $796,000
Q2 2022

Aug 09, 2022

BUY
$17.44 - $23.16 $869,540 - $1.15 Million
49,859 New
49,859 $1.04 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.